CRSP

CRISPR THERAPEUTICS AG

Healthcare | Mid Cap

-$1.44

EPS Forecast

$6.62

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2025-09-30
RGENRepligen CorpNBIXNeurocrine Biosciences IncMRNAModerna IncHALOHalozyme Therapeutics IncNVAXNovavax IncREPLReplimune Group IncTECHBio-techne CorpIOVAIovance Biotherapeutics IncDNLIDenali Therapeutics Inc